 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, October 1, 2003, 23(26):8949-8954
Previous Article | Next Article
BRIEF COMMUNICATION
The Neurofibromatosis 1 Gene Product Neurofibromin Regulates Pituitary Adenylate Cyclase-Activating Polypeptide-Mediated Signaling in Astrocytes
Biplab Dasgupta, Laura L. Dugan, andDavid H. Gutmann Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110
Individuals with the neurofibromatosis 1 (NF1)-inherited tumor predisposition syndrome develop low-grade astrocytomas. The NF1 tumor suppressor gene product neurofibromin exhibits GTPase-activating activity (GAP) toward RAS, such that loss of neurofibromin expression leads to high levels of activated RAS and increased cell proliferation. Previous work has demonstrated that Nf1 inactivation in astrocytes leads to increased cell proliferation in vitro and in vivo, accompanied by increased RAS pathway activation. Studies on Nf1 mutant Drosophila have suggested that neurofibromin might also regulate cAMP signaling. Because intracellular cAMP levels have profound effects on astrocyte growth control, we sought to determine the contribution of neurofibromin to astrocyte cAMP regulation. In this report, we demonstrate that Nf1 inactivation in astrocytes results in reduced cAMP generation in response to PACAP and attenuated calcium influx and Rap1 activation. Based on the differential effects of forskolin and dibutyryl-cAMP on Nf1-/- astrocytes, neurofibromin likely functions at the level of adenylyl cyclase activation. Last, the reintroduction of a fragment of neurofibromin containing residues sufficient for restoring RAS-GAP function in Nf1-/- cells resulted in only partial restoration of neurofibromin-mediated cAMP regulation. These results demonstrate that neurofibromin positively influences cAMP generation and activation of cAMP growth regulatory targets in astrocytes and expands the role of the NF1 gene in astrocyte growth regulation.
Key words: cAMP; glia; RAS; GAP; Rap1; astrocyte
Received June 24, 2003; revised August 11, 2003; accepted August 13, 2003.
This article has been cited by other articles:
D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, O. Wurtz, A. Fournier, B. K. C. Chow, H. Hashimoto, L. Galas, et al.
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
Pharmacol. Rev., September 1, 2009; 61(3): 283 - 357.
[Abstract] [Full Text] [PDF]
V. C. Williams, J. Lucas, M. A. Babcock, D. H. Gutmann, B. Korf, and B. L. Maria
Neurofibromatosis Type 1 Revisited
Pediatrics, January 1, 2009; 123(1): 124 - 133.
[Abstract] [Full Text] [PDF]
D. H. Gutmann
Using Neurofibromatosis-1 to Better Understand and Treat Pediatric Low-Grade Glioma
J Child Neurol, October 1, 2008; 23(10): 1186 - 1194.
[Abstract] [PDF]
B. Hegedus, T.-H. Yeh, D. Y. Lee, R. J. Emnett, J. Li, and D. H. Gutmann
Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis
Hum. Mol. Genet., October 1, 2008; 17(19): 2956 - 2966.
[Abstract] [Full Text] [PDF]
N. M. Warrington, B. M. Woerner, G. C. Daginakatte, B. Dasgupta, A. Perry, D. H. Gutmann, and J. B. Rubin
Spatiotemporal Differences in CXCL12 Expression and Cyclic AMP Underlie the Unique Pattern of Optic Glioma Growth in Neurofibromatosis Type 1
Cancer Res., September 15, 2007; 67(18): 8588 - 8595.
[Abstract] [Full Text] [PDF]
B. Bausch, W. Borozdin, V. F. Mautner, M. M. Hoffmann, D. Boehm, M. Robledo, A. Cascon, T. Harenberg, F. Schiavi, C. Pawlu, et al.
Germline NF1 Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients with Pheochromocytoma and Neurofibromatosis Type 1
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2784 - 2792.
[Abstract] [Full Text] [PDF]
Y.-L. Lin, Y.-T. Lei, C.-J. Hong, and Y.-P. Hsueh
Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena/VASP pathway
J. Cell Biol., June 21, 2007; 177(5): 829 - 841.
[Abstract] [Full Text] [PDF]
I. S. Ho, F. Hannan, H.-F. Guo, I. Hakker, and Y. Zhong
Distinct Functional Domains of Neurofibromatosis Type 1 Regulate Immediate versus Long-Term Memory Formation
J. Neurosci., June 20, 2007; 27(25): 6852 - 6857.
[Abstract] [Full Text] [PDF]
G. C. Daginakatte and D. H. Gutmann
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth
Hum. Mol. Genet., May 1, 2007; 16(9): 1098 - 1112.
[Abstract] [Full Text] [PDF]
L. Yang, E. Jackson, B. M. Woerner, A. Perry, D. Piwnica-Worms, and J. B. Rubin
Blocking CXCR4-Mediated Cyclic AMP Suppression Inhibits Brain Tumor Growth In vivo
Cancer Res., January 15, 2007; 67(2): 651 - 658.
[Abstract] [Full Text] [PDF]
P. H. Taghert and O. T. Shafer
Mechanisms of Clock Output in the Drosophila Circadian Pacemaker System
J Biol Rhythms, December 1, 2006; 21(6): 445 - 457.
[Abstract] [PDF]
J. A. Walker, A. V. Tchoudakova, P. T. McKenney, S. Brill, D. Wu, G. S. Cowley, I. K. Hariharan, and A. Bernards
Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons
Genes & Dev., December 1, 2006; 20(23): 3311 - 3323.
[Abstract] [Full Text] [PDF]
F. Hannan, I. Ho, J. J. Tong, Y. Zhu, P. Nurnberg, and Y. Zhong
Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras
Hum. Mol. Genet., April 1, 2006; 15(7): 1087 - 1098.
[Abstract] [Full Text] [PDF]
B. Dasgupta and D. H. Gutmann
Neurofibromin Regulates Neural Stem Cell Proliferation, Survival, and Astroglial Differentiation In Vitro and In Vivo
J. Neurosci., June 8, 2005; 25(23): 5584 - 5594.
[Abstract] [Full Text] [PDF]
B. Dasgupta, Y. Yi, D. Y. Chen, J. D. Weber, and D. H. Gutmann
Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1-Associated Human and Mouse Brain Tumors
Cancer Res., April 1, 2005; 65(7): 2755 - 2760.
[Abstract] [Full Text] [PDF]
B. Dasgupta, W. Li, A. Perry, and D. H. Gutmann
Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes
Cancer Res., January 1, 2005; 65(1): 236 - 245.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|